Inventor · disambiguated record
Martin A. Cheever
Also filed as: CHEEVER MARTIN A
27 granted patents·13 pending applications·1,392 citations·filing 1992–2012
98Inventor score
Top patents by PatentIndex Score
40 records- 0198US5869445AMethods for eliciting or enhancing reactivity to HER-2/neu proteinUNIV WASHINGTON·Filed 1996·Granted Feb 9, 1999·287 cites·4 claims
- 0298US5801005AImmune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 1995·Granted Sep 1, 1998·296 cites·7 claims
- 0398US5726023AImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 1995·Granted Mar 10, 1998·181 cites·20 claims
- 0496US5846538AImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associatedUNIV WASHINGTON·Filed 1995·Granted Dec 8, 1998·122 cites·6 claims
- 0594US7368119B2Compositions and methods for WT1 specific immunotherapyCORIXA CORP·Filed 2006·Granted May 6, 2008·13 cites·18 claims
- 0694US5876712AImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 1995·Granted Mar 2, 1999·127 cites·7 claims
- 0792US7115272B1Compositions and methods for WT1 specific immunotherapyUNIV WASHINGTON·Filed 2000·Granted Oct 3, 2006·35 cites·4 claims
- 0891US7144581B2Compositions and methods for WT1 specific immunotherapyCORIXA CORP·Filed 2001·Granted Dec 5, 2006·35 cites·5 claims
- 0988US7655239B2Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 2007·Granted Feb 2, 2010·2 cites·8 claims
- 1088US6075122AImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 1995·Granted Jun 13, 2000·36 cites·2 claims
- 1185US7375091B2HER-2/neu fusion proteinsCORIXA CORP·Filed 2001·Granted May 20, 2008·14 cites·22 claims
- 1285US7063854B1Composition and methods for WTI specific immunotherapyUNIV WASHINGTON·Filed 1998·Granted Jun 20, 2006·59 cites·2 claims
- 1384US7198920B1HER-2/neu fusion proteinsCORIXA CORP·Filed 2000·Granted Apr 3, 2007·8 cites·56 claims
- 1483US7662386B2Compositions and methods for WT1 specific immunotherapyCORIXA CORP·Filed 2007·Granted Feb 16, 2010·16 cites·18 claims
- 1582US7901693B2Compositions and methods for WT1 specific immunotherapyCORIXA CORP·Filed 2001·Granted Mar 8, 2011·11 cites·9 claims
- 1682US6664370B2Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 1999·Granted Dec 16, 2003·35 cites·48 claims
- 1779US7229623B1Her-2/neu fusion proteinsCORIXA CORP·Filed 2000·Granted Jun 12, 2007·14 cites·39 claims
- 1879US5320947AImmune reactivity to expressed activated oncogenes for diagnosis of malignancyWASHINGTON RES FOUND·Filed 1992·Granted Jun 14, 1994·28 cites·2 claims
- 1975US5601989AImmune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancyWASHINGTON RES FOUND·Filed 1994·Granted Feb 11, 1997·23 cites·20 claims
- 2074US2010087621A1Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associatedUNIV WASHINGTON·Filed 2009·Application pending·0 cites
- 2168US7329410B1Compositions and method for WT1 specific immunotherapyCORIXA CORP·Filed 2000·Granted Feb 12, 2008·17 cites·2 claims
- 2263US8568733B2HER-2/neu fusion proteinsCHEEVER MARTIN A·Filed 2008·Granted Oct 29, 2013·0 cites·7 claims
- 2362US2006121046A1Compositions and methods for WT1 specific immunotherapyUNIV WASHINGTON·Filed 2006·Application pending·0 cites
- 2460US7247703B2Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 2003·Granted Jul 24, 2007·7 cites·5 claims
- 2560US2006008479A1Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteinsUNIV WASHINGTON·Filed 2005·Application pending·0 cites
- 2659US5773230AImmune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancyWASHINGTON RES FOUND·Filed 1995·Granted Jun 30, 1998·11 cites·3 claims
- 2758US8524491B2Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associatedCHEEVER MARTIN A·Filed 2009·Granted Sep 3, 2013·0 cites·10 claims
- 2856US6942862B2Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteinsUNIV WASHINGTON·Filed 1998·Granted Sep 13, 2005·7 cites·3 claims
- 2955US2004235070A1Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancyWASHINGTON RES FOUND·Filed 2003·Application pending·0 cites
- 3054US7601697B2Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 2005·Granted Oct 13, 2009·0 cites·1 claims
- 3151US2003157119A1Methods for diagnosis and therapy of hematological and virus-associated malignanciesCORIXA CORP·Filed 2002·Application pending·0 cites
- 3249US2003039635A1Compositions and methods for WT1 specific immunotherapyCORIXA CORP·Filed 2002·Application pending·0 cites
- 3347US2002039573A1Compounds and methods for prevention and treatment of HER-2/neu associated malignanciesFiled 2001·Application pending·0 cites
- 3447US2012301492A1Compositions and methods for wt1 specific immunotherapyGAIGER ALEXANDER·Filed 2012·Application pending·0 cites
- 3546US2002193329A1Compositions and methods for the therapy and diagnosis of Her-2/neu-associated malignanciesCORIXA CORP·Filed 2001·Application pending·0 cites
- 3646US2003082194A1Compositions and methods for diagnosis and therapy of malignant mesotheliomaFiled 2001·Application pending·0 cites
- 3745US6953573B1Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associatedUNIV WASHINGTON·Filed 1998·Granted Oct 11, 2005·8 cites·3 claims
- 3843US2003235557A1Compositions and methods for WT1 specific immunotherapyCORIXA CORP·Filed 2002·Application pending·0 cites
- 3938US2010166738A1Compositions and methods for wt1 specific immunotherapyGAIGER ALEXANDER·Filed 2009·Application pending·0 cites
- 4029US2003083229A1Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancyFiled 1995·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →